Hungarian firm Gedeon Richter is to expand further its sizeable women’s health portfolio after agreeing to acquire Janssen’s Evra (ethinyl estradiol/norelgestromin) transdermal patch outside of the US for more than a quarter of a billion dollars.
Gedeon Richter is to enhance its existing branded female healthcare franchise worldwide and tap into transdermal patch formulations after signing an agreement to acquire Janssen’s Evra (ethinyl estradiol/norelgestromin) outside of the US for $263.5m.
The Johnson & Johnson subsidiary is to provide support to Richter to smooth the transfer of the marketing authorizations, including...
Melinta Therapeutics has prevailed at the Federal Circuit in a patent dispute over its reformulated intravenous antibiotic Minocin, with the appeals court upholding both infringement and validity and leaving Nexus Pharmaceuticals barred from launching a generic until 2031.
Mounjaro, Eliquis, and Darzalex buck the Q1 trend to make gains
